Who is the CEO of Valbiotis SA?

The CEO of Valbiotis SA is Sebastien Peltier HDR,.

What industry does Valbiotis SA belong to?

Valbiotis SA operates in the Biotechnology industry within the Healthcare sector.

Where is Valbiotis SA headquartered?

Valbiotis SA is headquartered at rue Paul Vatine, Périgny, 17180, FR.

What is the IPO date of Valbiotis SA?

Valbiotis SA went public on June 7, 2017.

How many employees does Valbiotis SA have?

Valbiotis SA has approximately 44 full-time employees.

Valbiotis SA

ALVAL.PA•EURONEXT

Healthcare

Biotechnology

€0.89

€-0.01(-1.33%)

Valbiotis SA (ALVAL.PA) Company Profile & Overview

Explore Valbiotis SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Valbiotis SA (ALVAL.PA) Company Profile & Overview

Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.

SectorHealthcare

IndustryBiotechnology

CEOSebastien Peltier HDR,

Contact Information

https://www.valbiotis.com

33 5 46 28 62 58

rue Paul Vatine, Périgny, 17180

Company Facts

44 Employees

IPO DateJun 7, 2017

CountryFR

Actively Trading

Frequently Asked Questions

;